Chronic kidney disease trials recruiting in Michigan

All Chronic kidney disease trials nationally

Cities in Michigan

Recruiting trials in Michigan

• A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
  NCT06830629 · Phase: Phase 2 · Ages: 18 Years to 68 Years · Sex: All (male and female) · Michigan: Dearborn, Flint, Pontiac, Saint Joseph
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit, Garden City, Saint Joseph
• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
  NCT07662135 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Saint Joseph
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Flint
• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
  NCT07268638 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Livonia, Pontiac
• A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
  NCT06749457 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Michigan: Detroit, Pontiac
• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
  NCT06712654 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Shelby
• A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
  NCT03619850 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Michigan: Detroit
• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
  NCT07753993 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit, Flint, Saginaw, Saint Joseph
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
  NCT07024823 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Michigan: Ann Arbor
• Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center
  NCT01016613 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
  NCT05334069 · Phase: Not specified · Ages: 40 Years to 75 Years · Sex: All (male and female) · Michigan: Alma, Alpena, Ann Arbor, Battle Creek
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
  NCT05485961 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Kalamazoo, Pontiac, Roseville, Saint Clair Shores
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Saint Joseph, Shelby
• Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
  NCT03836482 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
  NCT06906640 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
  NCT06906627 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor
• Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
  NCT05465044 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Detroit
• Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
  NCT06190717 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 84 Years · Sex: All (male and female) · Michigan: Lansing
• SAfety of Regional Citrate Anticoagulation (SARCA Study)
  NCT05339139 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Michigan: Ann Arbor, Detroit
• SPYRAL GEMINI Pilot Study
  NCT06907147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Michigan: Southfield
• Study of BHV-1400 in IgA Nephropathy
  NCT07054684 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Michigan: Shelby
• Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
  NCT07271186 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Michigan: Ann Arbor, Pontiac
• Transformative Research in Diabetic Nephropathy
  NCT02986984 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Michigan: Ann Arbor
• University of Michigan "Nephrology Research BioBank"
  NCT00381121 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Michigan: Ann Arbor